Intensity Therapeutics Inc, a developer of cancer immunotherapy products, has raised $10 million in financing. The investors included Batterson Venture Capital, VCapital, FastForward Innovations and SalvaRx Group PLC.
Source: Press Release
Intensity Therapeutics Inc, a developer of cancer immunotherapy products, has raised $10 million in financing. The investors included Batterson Venture Capital, VCapital, FastForward Innovations and SalvaRx Group PLC.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: